Author of the publication

Persistent antagonism of methamphetamine-induced dopamine release in rats pretreated with GBR12909 decanoate

, , , , , and . J Pharmacol Exp Ther, 301 (3): 1190-1197 (June 2002)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Oxygenated analogues of 1-2-(Diphenylmethoxy)ethyl- and 1-2-Bis(4-fluorophenyl)methoxyethyl-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents, , , , , , , , and . J Med Chem, 42 (24): 5029-5042 (December 1999)Development of long-acting dopamine transporter ligands as potential cocaine-abuse therapeutic agents: chiral hydroxyl-containing derivatives of 1-2-bis(4-fluorophenyl)methoxyethyl-4-(3-phenylpropyl)piperazine and 1-2-(diphenylmethoxy)ethyl-4-(3-phenylpropyl)piperazine, , , , , , , and . J Med Chem, 45 (6): 1321-1329 (March 2002)Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction, , , and . Biochem Pharmacol, 75 (1): 2-16 (January 2008)A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909, and . Mol Neurobiol, 11 (1-3): 1-19 (August 1995)Persistent antagonism of methamphetamine-induced dopamine release in rats pretreated with GBR12909 decanoate, , , , , and . J Pharmacol Exp Ther, 301 (3): 1190-1197 (June 2002)GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by (11)Craclopride continuous infusion PET scans, , , , , , , , and . Synapse, 33 (4): 268-273 (September 1999)